David Højland Ipsen
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Diet, Metabolism, and Disease, Liver Diseases and Immunity, Liver Disease and Transplantation, Liver physiology and pathology
Most-Cited Works
- → Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease(2018)1,394 cited
- → A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease(2018)190 cited
- → Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?(2021)91 cited
- → Does Vitamin C Deficiency Promote Fatty Liver Disease Development?(2014)67 cited
- → Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non‐Alcoholic Steatohepatitis(2018)53 cited
- → Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?(2020)53 cited
- → Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs(2015)52 cited
- → Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair(2025)51 cited
- → Normal weight dyslipidemia: Is it all about the liver?(2016)51 cited
- → Dyslipidemia: Obese or Not Obese—That Is Not the Question(2016)42 cited